Ftse Mib
34.395,62
0,06%
DAX
18.524,98
-0,40%
S&P 500
5.648,61
0,31%
NASDAQ
18.457,09
-0,08%
Bitcoin
64.594,64
-0,40%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

APLT

Applied Therapeutics (APLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT
DataOraFonteTitoloSimboloCompagnia
14/11/202204:55TipRanksRobert W. Baird Remains a Buy on Applied Therapeutics (APLT)NASDAQ:APLTApplied Therapeutics Inc
09/11/202213:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APLTApplied Therapeutics Inc
09/11/202213:00GlobeNewswire Inc.Applied Therapeutics Reports Third Quarter 2022 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
31/10/202212:00GlobeNewswire Inc.Applied Therapeutics Announces Multiple Data Presentations at the American Heart Association Scientific Sessions November 5-7, 2022NASDAQ:APLTApplied Therapeutics Inc
27/10/202207:55TipRanksApplied Therapeutics (APLT) Receives a Buy from Robert W. BairdNASDAQ:APLTApplied Therapeutics Inc
25/10/202213:00GlobeNewswire Inc.Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF Trial of AT-001 in Diabetic CardiomyopathyNASDAQ:APLTApplied Therapeutics Inc
14/10/202221:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APLTApplied Therapeutics Inc
14/10/202200:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APLTApplied Therapeutics Inc
06/10/202213:00GlobeNewswire Inc.Applied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids Pediatric Trial; Trial Will Continue to 18 Months in Blinded FormatNASDAQ:APLTApplied Therapeutics Inc
09/09/202222:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:APLTApplied Therapeutics Inc
09/09/202222:16Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APLTApplied Therapeutics Inc
26/08/202222:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:APLTApplied Therapeutics Inc
12/08/202213:00GlobeNewswire Inc.Applied Therapeutics Reports Second Quarter 2022 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
04/08/202223:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APLTApplied Therapeutics Inc
28/07/202213:00GlobeNewswire Inc.Applied Therapeutics to Sponsor and Present at the 2022 Galactosemia Foundation ConferenceNASDAQ:APLTApplied Therapeutics Inc
08/07/202218:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APLTApplied Therapeutics Inc
24/06/202222:38Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APLTApplied Therapeutics Inc
23/06/202204:12GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and WarrantsNASDAQ:APLTApplied Therapeutics Inc
22/06/202222:10GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Public Offering of Common Stock and WarrantsNASDAQ:APLTApplied Therapeutics Inc
03/06/202213:00GlobeNewswire Inc.Applied Therapeutics Receives Orphan Medicinal Product Designation from the EMA for AT-007 for Treatment of GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
19/05/202213:00GlobeNewswire Inc.Applied Therapeutics to Present at the UBS Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
14/05/202206:18TipRanksRobert W. Baird Thinks Applied Therapeutics’ Stock is Going to RecoverNASDAQ:APLTApplied Therapeutics Inc
12/05/202212:59GlobeNewswire Inc.Applied Therapeutics Reports First Quarter 2022 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
05/05/202213:30GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022 Annual Meeting of the Peripheral Nerve SocietyNASDAQ:APLTApplied Therapeutics Inc
04/04/202213:30GlobeNewswire Inc.Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic DisordersNASDAQ:APLTApplied Therapeutics Inc
16/03/202212:30GlobeNewswire Inc.Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and GenomicsNASDAQ:APLTApplied Therapeutics Inc
12/03/202204:53TipRanksApplied Therapeutics (APLT) Gets a Buy Rating from Robert W. BairdNASDAQ:APLTApplied Therapeutics Inc
10/03/202215:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APLTApplied Therapeutics Inc
10/03/202213:30GlobeNewswire Inc.Applied Therapeutics Reports Fourth Quarter and Year-end 2021 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
10/03/202212:33Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APLTApplied Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT

La tua Cronologia

UNSW3
YAXISETH
yAxis V2
AQEU
CBKD
Commerzbank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network